Safety and efficacy of the CD95-ligand inhibitor asunercept in transfusion-dependent patients with low and intermediate risk MDS

Myelodysplastic syndromes (MDS) are a group of heterogeneous oligoclonal stem cell disorders characterized by peripheral cytopenia and a risk of transformation into acute myeloid leukemia (AML). Anemia is the most frequent symptom and reflects the impaired erythroid cell maturation.

Source: Leukemia Research - March 10, 2018 Category: Hematology Authors: Tobias Boch, Thomas Luft, Georgia Metzgeroth, Maximilian Mossner, Johann-Christoph Jann, Daniel Nowak, Franziska La Meir, Christiane Schumann, Jennifer Klemmer, Susanne Brendel, Harald Fricke, Claudia Kunz, Christel Wei ß, Wolf-Karsten Hofmann, Florian N Tags: Research paper Source Type: research